课题基金 / 基金详情

The Variation of the NK Cell Receptome in Pemphigus

The Variation of the NK Cell Receptome in Pemphigus
天疱疮NK细胞受体组的变异
批准号:
10750358
负责人:
Danillo G Augusto
金额:
$68.03万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2028-05-31

项目摘要

项目成果

Danillo G Augusto的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 天疱疮是一个宽泛的术语,指的是潜在威胁生命的自身免疫性水疱性皮肤病的子集。 在美国,每10万名成年人中有5.2例。几个遗传变异显著增加 PF风险,包括主要组织相容性复合体(MHC)内的变异,如人类白细胞 抗原(HL A)I、II类基因。PI在揭示易感基因方面做出了重大贡献 PF的变异,包括最近的一项全基因组关联研究。值得注意的是,编码基因的变异 天然的NK受体与PF的易感性密切相关,其中一些关联是 用差异表达水平来解释。尽管有令人信服的证据表明NK细胞受体的作用 自身免疫性水疱性皮肤病的变异,NK细胞在调节天疱疮风险中的确切功能 人们对结果也知之甚少。总体目标是开发一个全面的序列图和 天疱疮患者整个NK细胞受体的结构变异,由大约90个基因编码 LRC(白细胞受体复合体)和NKC(自然杀伤复合体)。为NK的作用带来新的见解 在疾病中,我们将表征NK受体基因变异的性质和关联程度 通过我们的新型高通量、高分辨率下一代测序(NGS)分析实现,并应用于 在一组不同的、成熟的和特征良好的队列中。使用最先进的方法,我们将 通过考虑疾病中的NK细胞表型来了解这种基因组变异。最后,我们将探讨 观察到的NK受体变异的功能含义,允许从机制上解释这种影响 以更好地了解这些高度可变的受体在天疱疮和蛋鸡中的作用 这是理解疾病机制的基础。随着我们的目标是探索和发现监管 机制,我们的研究将极大地扩大对NK细胞生物学、细胞毒性和 功能。我们的最终目标是揭示为疾病的发展奠定基础的生物过程。 通过发现NK细胞介导的免疫疗法的潜在靶点来理解和治疗。
英文摘要
ABSTRACT Pemphigus is a broad term denoting a subset of potentially life-threatening autoimmune blistering skin diseases with a prevalence of 5.2 cases per 100,000 adults in the United States. Several genetic variants strongly increase PF risk, including variants within the major histocompatibility complex (MHC), such as the human leukocyte antigen (HLA) class I and II genes. The PI has contributed significantly to uncovering susceptibility genetic variants in PF, including a recent genome-wide association study. Remarkably, variants in genes encoding natural NK receptors have been strongly associated with PF susceptibility, and some of these associations were explained by differential expression levels. Despite the compelling evidence for the role of NK cell receptor variation in this autoimmune blistering skin disease, the precise function of NK cells in mediating pemphigus risk and outcomes is poorly understood. The overall goal is to develop a comprehensive map of sequence and structural variation of the entire NK cell receptome in pemphigus, encoded by approximately 90 genes within the LRC (leukocyte receptor complex) and NKC (natural killer complex). To bring novel insights about the role of NK cells in disease, we will characterize the nature and extent of the association of genetic variation of NK receptors achieved via our novel high-throughput, high-resolution next-generation sequencing (NGS) assays and applied across a set of diverse, established, and well-characterized cohorts. Using state-of-art methods, we will contextualize this genomic variation by considering NK cell phenotype in disease. Finally, we will explore the functional implications of the observed NK receptor variation, allowing a mechanistic explanation of the impact of NK receptor expression to understand better the role of these highly variable receptors in pemphigus and lay the foundation for understanding disease mechanisms. As we aim to explore and uncover regulatory mechanisms, our research will significantly expand the comprehension of NK cell biology, cytotoxicity, and function. Our ultimate goal is to reveal biological processes that lay the foundation for advancing disease comprehension and treatment by discovering potential targets for NK-cell-mediated immunotherapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining Variation in the Natural Killer Cell Receptome in Human Populations
Defining Variation in the Natural Killer Cell Receptome in Human Populations
Diversity Supplement: Defining Variation in the Natural Killer Cell Receptome in Human Populations
海外基金